GoodRx Holdings, Inc.
For the period ended Sep 30, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 4, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| (in thousands) | 2025 | 2024 |
| Cash flows from operating activities | ||
| Net income | $25,014 | $9,650 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 62,072 | 50,442 |
| Loss on extinguishment of debt | — | 2,077 |
| Amortization of debt issuance costs and discounts | 1,314 | 2,076 |
| Non-cash operating lease expense | 3,063 | 2,981 |
| Stock-based compensation expense | 58,707 | 78,067 |
| Deferred income taxes | 8,089 | (642) |
| Loss on operating lease asset | 4,409 | — |
| Other | 476 | — |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (57,804) | 12,805 |
| Prepaid expenses and other assets | (23,233) | (12,268) |
| Accounts payable | 14,625 | (23,167) |
| Accrued expenses and other current liabilities | 42,208 | 19,778 |
| Operating lease liabilities | (4,732) | (3,250) |
| Other liabilities | 808 | 600 |
| Net cash provided by operating activities | 135,016 | 139,149 |
| Cash flows from investing activities | ||
| Purchase of property and equipment | (2,280) | (1,078) |
| Acquisition | (30,000) | — |
| Capitalized software | (55,910) | (52,625) |
| Net cash used in investing activities | (88,190) | (53,703) |
| Cash flows from financing activities | ||
| Proceeds from long-term debt | — | 472,033 |
| Payments on long-term debt | (3,750) | (639,038) |
| Payments of debt issuance costs | — | (2,673) |
| Repurchases of Class A common stock (1) | (206,942) | (158,657) |
| Proceeds from exercise of stock options | 61 | 18,435 |
| Employee taxes paid related to net share settlement of equity awards | (11,872) | (24,922) |
| Proceeds from employee stock purchase plan | 860 | 857 |
| Net cash used in financing activities | (221,643) | (333,965) |
| Net change in cash and cash equivalents | (174,817) | (248,519) |
| Cash and cash equivalents | ||
| Beginning of period | 448,346 | 672,296 |
| End of period | $273,529 | $423,777 |
| Supplemental disclosure of cash flow information | ||
| Non cash investing and financing activities: | ||
| Right-of-use assets obtained in exchange for operating lease liabilities | $9,098 | $1,894 |
| Stock-based compensation included in capitalized software | 12,145 | 12,313 |
| Capitalized software included in accounts payable and accrued expenses and other current liabilities | 8,206 | 7,515 |
(1)Repurchases of Class A common stock for thenine months ended September 30, 2025 and 2024 include 20.0
million and 20.9 million shares repurchased from related parties (after giving effect to the automatic conversion of
Class B common stock to Class A common stock upon such repurchase) for an aggregate consideration of$84.9
million and$151.4 million, respectively. See "Note 10. Stockholders' Equity" for additional information.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.